ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Selective Modulation of OTUB1 Noncanonical Function via a bioPhosTAC Strategy.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
OTUB1 is a canonical deubiquitinating enzyme that hydrolyzes K48-linked polyubiquitin chains as well as a regulator of several noncanonical pathways controlled by site-specific post-translational modifications. Phosphorylation at tyrosine 26 (Y26) of OTUB1 recently emerged as a key regulatory switch that stabilizes Raptor (central component of mTORC1), thereby enhancing mTORC1 activity and influencing cell growth and metabolism. Selective modulation of Y26 phosphorylation offers an opportunity to elucidate the noncanonical roles of OTUB1 without perturbing its catalytic activity. However, genetic or kinase inhibition strategies lack the specificity to separate these functions. Here, a tyrosine-specific targeted protein dephosphorylation strategy was developed by recruiting the protein tyrosine phosphatase, SHP2, to OTUB1 via a peptide-based bifunctional molecule, termed bioPhosTAC. This bioPhosTAC comprises an OTUB1-binding peptide linked to an SHP2-binding peptide through a short linker, enabling proximity-induced Y26 dephosphorylation. The bioPhosTAC selectively reduced OTUB1 Y26 phosphorylation resulted in Raptor-related mitochondrial fusion and Bim upregulation. This study represents the first demonstration of a peptide-based SHP2-mediated bioPhosTAC system for selective tyrosine dephosphorylation through induced proximity. These findings provide a new chemical biology tool for dissecting the noncanonical roles of OTUB1 and broaden the scope of targeted protein dephosphorylation strategies to tyrosine phosphorylation, potentially allowing precise modulation of phospho-dependent signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.